Yogic versus conventional treatment in diarrhea-predominant irritable bowel syndrome: A randomized control study

被引:69
|
作者
Taneja, I
Deepak, KK [1 ]
Poojary, G
Acharya, IN
Pandey, RM
Sharma, MP
机构
[1] All India Inst Med Sci, Dept Physiol, New Delhi 110029, India
[2] All India Inst Med Sci, Cent Council Res Yoga & Naturopathy, New Delhi, India
[3] All India Inst Med Sci, Dept Biostat, New Delhi, India
[4] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India
关键词
diarrhea-predominant irritable bowel syndrome; yogic intervention; autonomic functions; bowel symptoms; electrogastrography;
D O I
10.1023/B:APBI.0000017861.60439.95
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
This study was conducted to evaluate the comparative effect of yogic and conventional treatment in diarrhea-predominant irritable bowel syndrome (IBS) in a randomized control design. The patients were 22 males, aged 20-50 years, with confirmed diagnosis of diarrhea-predominant IBS. The conventional group (n = 12, 1 dropout) was given symptomatic treatment with loperamide 2-6 mg/day for 2 months, and the yogic intervention group ( n D 9) consisted of a set of 12 asanas ( yogic poses, i.e., Vajrasana, Shashankasana, Ushtrasana, Marjariasana, Padhastasana, Dhanurasana, Trikonasana in two variations, Pawanmuktasana, and Paschimottanasana) along with Surya Nadi pranayama ( right-nostril breathing) two times a day for 2 months. All participants were tested at three regular intervals, at the start of study - 0 month, 1 month, and 2 months of receiving the intervention - and were investigated for bowel symptoms, autonomic symptoms, autonomic reactivity ( battery of five standard tests), surface electrogastrography, anxiety profile by Spielberger's Self Evaluation Questionnaire, which evaluated trait and state anxiety. Two months of both conventional and yogic intervention showed a significant decrease of bowel symptoms and state anxiety. This was accompanied by an increase in electrophysiologically recorded gastric activity in the conventional intervention group and enhanced parasympathetic reactivity, as measured by heart rate parameters, in yogic intervention group. The study indicates a beneficial effect of yogic intervention over conventional treatment in diarrhea-predominant IBS.
引用
收藏
页码:19 / 33
页数:15
相关论文
共 50 条
  • [21] Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii
    Bafutto, Mauro
    Almeida, Jose R.
    Leite, Nayle V.
    Rezende Filho, Joffre
    GASTROENTEROLOGY, 2008, 134 (04) : A527 - A527
  • [22] Targeted therapies for diarrhea-predominant irritable bowel syndrome
    Olden, Kevin W.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2012, 5 : 69 - 100
  • [23] Medical Therapies for Diarrhea-Predominant Irritable Bowel Syndrome
    Sayuk, Gregory S.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2021, 50 (03) : 611 - 637
  • [24] Clinical study on acupuncture in treating diarrhea-predominant irritable bowel syndrome
    Liu H.-R.
    Yang Y.
    Wu H.-G.
    Journal of Acupuncture and Tuina Science, 2008, 6 (6) : 360 - 362
  • [25] Clinical Study on Acupuncture in Treating Diarrhea-predominant Irritable Bowel Syndrome
    刘慧荣
    杨允
    吴焕淦
    肖元春
    Journal of Acupuncture and Tuina Science, 2008, 6 (06) : 360 - 362
  • [26] Effect of acupuncture for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized clinical trial
    Ling-Yu Qi
    Jing-Wen Yang
    Shi-Yan Yan
    Yan-Fen She
    Hui Hu
    Ying Li
    Li-Li Chi
    Bang-Qi Wu
    Jian-Feng Tu
    Li-Qiong Wang
    Cun-Zhi Liu
    Trials, 23
  • [27] Effect of acupuncture for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized clinical trial
    Qi, Ling-Yu
    Yang, Jing-Wen
    Yan, Shi-Yan
    She, Yan-Fen
    Hu, Hui
    Li, Ying
    Chi, Li-Li
    Wu, Bang-Qi
    Tu, Jian-Feng
    Wang, Li-Qiong
    Liu, Cun-Zhi
    TRIALS, 2022, 23 (01)
  • [28] Electroacupuncture for patients with diarrhea-predominant irritable bowel syndrome or functional diarrhea A randomized controlled trial
    Zheng, Hui
    Li, Ying
    Zhang, Wei
    Zeng, Fang
    Zhou, Si-Yuan
    Zheng, Hua-Bin
    Zhu, Wen-Zeng
    Jing, Xiang-Hong
    Rong, Pei-Jing
    Tang, Chun-Zhi
    Wang, Fu-Chun
    Liu, Zhi-Bin
    Wang, Shi-Jun
    Zhou, Mei-Qi
    Liu, Zhi-Shun
    Zhu, Bing
    MEDICINE, 2016, 95 (24)
  • [29] Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndrome
    Bruzzese, Eugenia
    Pesce, Marcella
    Sarnelli, Giovanni
    Guarino, Alfredo
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (07) : 753 - 760
  • [30] ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome
    Oh, Ah-Reum
    Sohn, Seonyong
    Lee, Junghoon
    Park, Jong-Min
    Nam, Ki Taek
    Hahm, Ki-Baik
    Kim, Young-Bum
    Lee, Ho-Jae
    Cha, Ji-Young
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2018, 85 : 286 - 297